|
From
Functional Genomics to Anti-Cancer Drug Discovery |
|
Dalian
. China |
|
Oct.18,
2003 |
|
|
|
Speakers |
|
|
|
|
|
|
 |
|
Zhijian
Chen, Ph.D.
Associate Professor
Department of Molecular Biology
University of Texas Southwestern Medical Center at Dallas
|
|
|
Title:
Ubiquitin Signaling in the NF-kB Pathway |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Yibin
Xiang, Ph. D.
TaiGen Biotech Co., Ltd.
|
|
|
|
|
|
|
Tilte:
GPCRs as Drug Discovery Targets --- Introduction of Taigen Biotechnology |
|
|
|
|
|
|
|
|
|
 |
|
Vladimir Khavinson, Ph.D.
Member of the Russian Academy of Natural Sciences
Director of the Institute of Bioregulation and Gerontology
Russian Academy of Natural Sciences
|
|
|
|
Title:
Title: Peptides, Genome & Life Extension |
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
Zhi Hong٬Ph.D.
Vice President of Drug Discovery,
ICN/Ribapharm, Costa Mesa |
|
|
|
Title:
Title: Recent Advances in Therapies for Viral Hepatitis |
|
|
|
|
|
|
|
|
|
|
 |
|
Jun
Li, Ph.D.
Senior Principal Scientist, I
nflammation/Immunology Dept.,
Boehringer Ingelheim Pharmaceuticals
|
|
|
|
Title:
Target Identification and Target Validation by Genomic Approaches |
|
|
|
|
|
|
|
|
|